1. Qun Yu; Maojuan Guo; Wenyun Zeng; Miao Zeng; Xiaolu Zhang; Yue Zhang; Wenlan Zhang;Xijuan Jiang; Bin Yu ; Interactions between NLRP3 inflammasome and glycolysis in macrophages_ New insights into chronic inflammation pathogenesis, Immunity,Inflammation and Disease, 2022, 10(3):e581-e581 2. Qiuyue Yang; Qun Yu; Wenyun Zeng; Miao Zeng; Xiaolu Zhang; Yilin Zhang; Lin Guo; Xijuan Jiang; Jiali Gan ; Killing two birds with one stone: miR-126 involvement in both cancer and atherosclerosis, European Review for Medical and Pharmacological Sciences, 2022, 26: 6145-6168 3. Jiali Gan; Lin Guou; Xiaolu Zhang; Qun Yu; Qiuyue Yang; Yilin Zhang; Wenyun Zeng; Xijuan Jiang; Maojuan Guo ; Anti-inflammatory therapy of atherosclerosis: focusing on IKKβ, Journal of Inflammation, 2023, 20(1): 8-8 4. Xiaolu Zhang; Wenyun Zeng; Yue Zhang; Qun Yu; Miao Zeng; Jiali Gan; Wenlan Zhang; Xijuan Jiang; Huhu Li ; Focus on the role of mitochondria in NLRP3 inflammasome activation: A prospective target for the treatment of ischemic stroke (Review), International Journal of Molecular Medicine, 2022, 49(6): 74-74 5. Wenyun Zeng; Danbin Wu; Yingxin Sun; Yanrong Suo; Qun Yu; Miao Zeng; Qing Gao; Bin Yu;Xijuan Jiang; Yijing Wang ; The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages, Scientific Reports, 2021, 11 |
